« Back
Phenotypic Cell-Based Screening of a High Content Imaging Cell Health Assay using the IN Cell Analyzer 2000
Phenotypic Cell-Based Screening of a High Content Imaging Cell Health Assay using the IN Cell Analyzer 2000
Submitted on 17 May 2016

Zaynab Neetoo-Isseljee, Chido Mpamhanga, David Tickle, Debra Taylor and Janet Brownlees
MRC Technology
This poster was presented at High Content & Phenotypic Screening 2016
Poster Views: 908
View poster »
Poster Abstract
Cell health assays play a key role in early drug discovery as they provide a crucial means of ranking novel chemical or biotherapeutic leads during screening and help to gain a better understanding of changes at the cellular level in disease pathologies. Recently there has been the emergence of High Content Screening (HCS), which integrates cell based imaging with multiple readouts in relevant cells in a high-throughput format. This has allowed in vitro cell health assays to be developed into High Content Imaging assays and used for HCS where they employ a multi-parametric approach enabling the capture of both phenotypic and mechanistic information of the cells. High Content Screening of cell health assays is now commonly being used as an early predictive toxicity assay to evaluate compound toxicity, in particular hepatotoxicity.
We demonstrate how we established an in-house cell health assay to be used for high content phenotypic screening using the IN Cell Analyzer 2000 with the aim to screen subsets of MRCT compound libraries and in-house compounds. The assay development process is illustrated using drugs withdrawn from the market or known to cause hepatotoxicity as tool compounds and initial screening of the FDA set in HepG2 cells to validate the assay. Genedata Screener analysis software was used for data processing and to visualise the data generated from the high content imaging screen.

O’Brien PJ, et al. (2006). High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol. 80(9):580-604.Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Impurity Lifecycle Management: Visualising a Vast Array of NMR and Other Analytical Data
Steve Coombes1, John Nightingale1, Azalea Micottis1, Albert Van Wyk2, Peter Russel2, Dimitris Argyropoulos2, Stephane Albrecht2

Computer Assisted Structure Elucidation of Two Biflavonoids from the Leaves of Ochna Mauritiana
G.A. Dziwornu,1 N.R. Toorabally,2 M.G Bhowon,2 S. Jhaumeer-Laulloo,2 S. Sunassee,1,3 A. Moser,4 D. Argyropoulos5

Characterization of Heavily Contaminated Sites using NMR Spectroscopy
Darcy Fallaise,1 Brent G. Pautler,2 Arvin Moser,2 James G. Longstaffe1

Dr. Nitin Gupta

The Application of Powder Rheology for Evaluating the Flow Behaviour of Powders for Additive Manufacturing Applications
Jamie Clayton, Tim Freeman, Katrina Brockbank, Robert Deffley

Keep up to date
with the latest posters
Receive World Wide Exposure
Increase Collaboration